| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 1257-1263, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
AE Bielawska, JP Shapiro, L Jiang, HS Melkonyan, C Piot, CL Wolfe, LD Tomei, YA Hannun and SR Umansky
Department of Medicine, Duke University, Durham, North Carolina, USA.
Involvement of ceramide signaling in the initiation of apoptosis induction in myocardial cells by in vitro and in vivo ischemia and reperfusion was analyzed. Synthetic cell permeable C2-ceramide induced apoptotic death of rat neonatal cardiomyocytes in vitro. In vitro ischemia (oxygen/serum/glucose deprivation) led to a progressive accumulation of ceramide in cardiomyocytes. After 16 hours of simulated in vitro reperfusion (readdition of oxygen, serum and glucose), the level of ceramide in surviving cells was found to have returned to baseline, whereas, levels in nonadherent dead cells remained high. In the rat heart left coronary artery occlusion model, ischemia with the subsequent reperfusion, but not ischemia alone, induced apoptosis in myocardial cells as demonstrated by DNA electrophoresis and measurement of soluble chromatin degradation products. The content of ceramide in ischemic area was elevated to 155% baseline levels at 30 minutes, and to 330% after 210 minutes of ischemia. Ischemia (30 minutes) followed by reperfusion (180 minutes) increased the ceramide level to 250% in the ischemic area. The combination of results obtained in both in vitro and animal models demonstrate for the first time that ceramide signaling can be involved in ischemia/reperfusion death of myocardial cells.
This article has been cited by other articles:
![]() |
W. L. Holland and S. A. Summers Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism Endocr. Rev., June 1, 2008; 29(4): 381 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shtraizent, E. Eliyahu, J.-H. Park, X. He, R. Shalgi, and E. H. Schuchman Autoproteolytic Cleavage and Activation of Human Acid Ceramidase J. Biol. Chem., April 25, 2008; 283(17): 11253 - 11259. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Parra, V. Eisner, M. Chiong, A. Criollo, F. Moraga, A. Garcia, S. Hartel, E. Jaimovich, A. Zorzano, C. Hidalgo, et al. Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis Cardiovasc Res, January 15, 2008; 77(2): 387 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Szczepaniak, R. G. Victor, L. Orci, and R. H. Unger Forgotten but Not Gone: The Rediscovery of Fatty Heart, the Most Common Unrecognized Disease in America Circ. Res., October 12, 2007; 101(8): 759 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maceyka, S. Milstien, and S. Spiegel Shooting the Messenger: Oxidative Stress Regulates Sphingosine-1-Phosphate Circ. Res., January 5, 2007; 100(1): 7 - 9. [Full Text] [PDF] |
||||
![]() |
D. Pchejetski, O. Kunduzova, A. Dayon, D. Calise, M.-H. Seguelas, N. Leducq, I. Seif, A. Parini, and O. Cuvillier Oxidative Stress-Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A-Associated Cardiac Cell Apoptosis Circ. Res., January 5, 2007; 100(1): 41 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Jin and J. S. Karliner Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKC{varepsilon} dependent mechanism Cardiovasc Res, September 1, 2006; 71(4): 725 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Williams, A. Verhovez, A. Milan, F. Veglio, and P. Mulatero Protective Effect of Spironolactone on Endothelial Cell Apoptosis Endocrinology, May 1, 2006; 147(5): 2496 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Goikoetxea, J. Beaumont, A. Gonzalez, B. Lopez, R. Querejeta, M. Larman, and J. Diez Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease Cardiovasc Res, March 1, 2006; 69(4): 899 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gulbins and P. L. Li Physiological and pathophysiological aspects of ceramide Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R11 - R26. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Therade-Matharan, E. Laemmel, S. Carpentier, Y. Obata, T. Levade, J. Duranteau, and E. Vicaut Reactive oxygen species production by mitochondria in endothelial cells exposed to reoxygenation after hypoxia and glucose depletion is mediated by ceramide Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1756 - R1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chapman, C. Ramstrom, L. Korhonen, M. Laine, K. T. Wann, D. Lindholm, M. Pasternack, and K. Tornquist Downregulation of the HERG (KCNH2) K+ channel by ceramide: evidence for ubiquitin-mediated lysosomal degradation J. Cell Sci., November 15, 2005; 118(22): 5325 - 5334. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Argaud, A.-F. Prigent, L. Chalabreysse, J. Loufouat, M. Lagarde, and M. Ovize Ceramide in the antiapoptotic effect of ischemic preconditioning Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H246 - H251. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Liu and R. H. Kennedy Positive inotropic effect of ceramide in adult ventricular myocytes: mechanisms dissociated from its reduction in Ca2+ influx Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H735 - H744. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Singh and H. K. Saini Resident Cardiac Mast Cells and Ischemia-Reperfusion Injury Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 135 - 148. [Abstract] [PDF] |
||||
![]() |
N. W. O'Brien, N. M. Gellings, M. Guo, S. B. Barlow, C. C. Glembotski, and R. A. Sabbadini Factor Associated With Neutral Sphingomyelinase Activation and Its Role in Cardiac Cell Death Circ. Res., April 4, 2003; 92(6): 589 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Young, P. McNulty, and H. Taegtmeyer Adaptation and Maladaptation of the Heart in Diabetes: Part II: Potential Mechanisms Circulation, April 16, 2002; 105(15): 1861 - 1870. [Full Text] [PDF] |
||||
![]() |
C. R Holleyman and D. F Larson Apoptosis in the ischemic reperfused myocardium Perfusion, December 1, 2001; 16(6): 491 - 502. [Abstract] [PDF] |
||||
![]() |
H. BIRBES, S. EL BAWAB, Y. A. HANNUN, and L. M. OBEID Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis FASEB J, December 1, 2001; 15(14): 2669 - 2679. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Levade, N. Auge, R. J. Veldman, O. Cuvillier, A. Negre-Salvayre, and R. Salvayre Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology Circ. Res., November 23, 2001; 89(11): 957 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. TOMEI and S. R. UMANSKY Apoptosis and the Heart: A Brief Review Ann. N.Y. Acad. Sci., November 1, 2001; 946(1): 160 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gouaze, M.-E. Mirault, S. Carpentier, R. Salvayre, T. Levade, and N. Andrieu-Abadie Glutathione Peroxidase-1 Overexpression Prevents Ceramide Production and Partially Inhibits Apoptosis in Doxorubicin-Treated Human Breast Carcinoma Cells Mol. Pharmacol., September 1, 2001; 60(3): 488 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. UNGER and L. ORCI Diseases of liporegulation: new perspective on obesity and related disorders FASEB J, February 1, 2001; 15(2): 312 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Deng, S. M. Kornblau, P. P. Ruvolo, and W. S. May Jr. Regulation of Bcl2 Phosphorylation and Potential Significance for Leukemic Cell Chemoresistance J Natl Cancer Inst Monographs, December 1, 2000; 2000(28): 30 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Sparagna, D. L. Hickson-Bick, L. M. Buja, and J. B. McMillin A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2124 - H2132. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-T. Zhou, P. Grayburn, A. Karim, M. Shimabukuro, M. Higa, D. Baetens, L. Orci, and R. H. Unger Lipotoxic heart disease in obese rats: Implications for human obesity PNAS, February 15, 2000; 97(4): 1784 - 1789. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Semenza Cellular and Molecular Dissection of Reperfusion Injury : ROS Within and Without Circ. Res., February 4, 2000; 86(2): 117 - 118. [Full Text] [PDF] |
||||
![]() |
O. M. Hernandez, D. J. Discher, N. H. Bishopric, and K. A. Webster Rapid Activation of Neutral Sphingomyelinase by Hypoxia-Reoxygenation of Cardiac Myocytes Circ. Res., February 4, 2000; 86(2): 198 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yaoita, K. Ogawa, K. Maehara, and Y. Maruyama Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction Cardiovasc Res, February 1, 2000; 45(3): 630 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A Piot, J.-F. Martini, S. K Bui, and C. L Wolfe Ischemic preconditioning attenuates ischemia/reperfusion-induced activation of caspases and subsequent cleavage of poly(ADP-ribose) polymerase in rat hearts in vivo Cardiovasc Res, December 1, 1999; 44(3): 536 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bialik, V. L. Cryns, A. Drincic, S. Miyata, A. L. Wollowick, A. Srinivasan, and R. N. Kitsis The Mitochondrial Apoptotic Pathway Is Activated by Serum and Glucose Deprivation in Cardiac Myocytes Circ. Res., September 3, 1999; 85(5): 403 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. ANDRIEU-ABADIE, J.-P. JAFFRÉZOU, S. HATEM, G. LAURENT, T. LEVADE, and J.-J. MERCADIER L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation FASEB J, September 1, 1999; 13(12): 1501 - 1510. [Abstract] [Full Text] |
||||
![]() |
E. Delpy, S. N Hatem, N. Andrieu, C. de Vaumas, M. Henaff, C. Rucker-Martin, J.-P. Jaffrezou, G. Laurent, T. Levade, and J.-J. Mercadier Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes Cardiovasc Res, August 1, 1999; 43(2): 398 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Ruvolo, X. Deng, T. Ito, B. K. Carr, and W. S. May Ceramide Induces Bcl2 Dephosphorylation via a Mechanism Involving Mitochondrial PP2A J. Biol. Chem., July 16, 1999; 274(29): 20296 - 20300. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Condrescu and J. P. Reeves Inhibition of Sodium-Calcium Exchange by Ceramide and Sphingosine J. Biol. Chem., February 2, 2001; 276(6): 4046 - 4054. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Ruvolo, F. Gao, W. L. Blalock, X. Deng, and W. S. May Ceramide Regulates Protein Synthesis by a Novel Mechanism Involving the Cellular PKR Activator RAX J. Biol. Chem., April 6, 2001; 276(15): 11754 - 11758. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |